Ardelyx, Inc. (FRA:41X)
Germany · Delayed Price · Currency is EUR 4.959
-0.139 (-2.73%)
Last updated: Dec 1, 2025, 8:19 AM CET
Ardelyx Employees
Ardelyx had 395 employees as of December 31, 2024. The number of employees increased by 128 or 47.94% compared to the previous year.
Employees
395
Change (1Y)
128
Growth (1Y)
47.94%
Revenue / Employee
€859,278
Profits / Employee
€122,013
Market Cap
1.17B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 395 | 128 | 47.94% |
| Dec 31, 2023 | 267 | 134 | 100.75% |
| Dec 31, 2022 | 133 | 47 | 54.65% |
| Dec 31, 2021 | 86 | -43 | -33.33% |
| Dec 31, 2020 | 129 | 41 | 46.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Ardelyx News
- 24 days ago - Real-World Evidence Studies of XPHOZAH (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week - Wallstreet:Online
- 24 days ago - Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week - GlobeNewsWire
- 26 days ago - Ardelyx to Participate at the Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 26 days ago - Ardelyx: Impressive Q3 Record Growth - Why I Buy - Seeking Alpha
- 27 days ago - Ardelyx: A Long Overdue Rally - Seeking Alpha
- 27 days ago - Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference - GlobeNewsWire
- 4 weeks ago - Citigroup Raises Ardelyx (ARDX) Price Target to $11.00 with Buy Rating | ARDX Stock News - GuruFocus
- 4 weeks ago - Ardelyx (ARDX) Receives a Boost in Price Target from TD Cowen | ARDX Stock News - GuruFocus